Similar Items: Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report
- Anifrolumab in Refractory Dermatomyositis and Antisynthetase Syndrome
- Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?
- Novel use of anifrolumab in a young patient with Jo-1-positive juvenile dermatomyositis
- Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers
- Subcutaneous Emphysema and Severe Interstitial Lung Disease in the Setting of Anti-MDA 5 Positive Dermatomyositis in a Hispanic Patient
- Type I interferon overactivation in sera of patients with anti‐MDA5‐positive dermatomyositis‐associated interstitial lung disease